Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD. Issue 4 (1st April 2003)

• Record Type: Journal Article
• Authors: Sugiura, H; Ichinose, M; Yamagata, S; Koarai, A; Shirato, K; Hattori, T
• Is Part Of: Thorax. Volume 58:Issue 4(2003)
• Page Start: 299
• Page End: 305
• Publication Date: 2003-04-01
• Subjects: inducible nitric oxide synthase -- nitrotyrosine -- corticosteroids -- chronic obstructive pulmonary disease; Chest -- Diseases -- Periodicals; Thorax; Chest -- Diseases; Periodicals; Periodicals; 617.54
• DOI: 10.1136/thorax.58.4.299
• Languages: English
• ISSNs: 0040-6376

Abstract

Abstract : Background: Reactive nitrogen species (RNS) have a number of inflammatory actions and the production of these molecules has been reported to be increased in the airways of patients with chronic obstructive pulmonary disease (COPD), which suggests that they may be involved in the inflammatory and obstructive process in COPD. Methods: The relationship between the reduction in RNS and the improvement in pulmonary function was studied in 18 patients with COPD following steroid treatment (800 μg beclomethasone dipropionate inhalation for 4 weeks). Twelve patients were treated with inhaled steroids and the others received placebo treatment. Forced expiratory volume in 1 second (FEV1 ) and airway responsiveness to histamine were measured before and after treatment. Induced sputum cells were stained with anti-nitrotyrosine antibody, a footprint of RNS, and RNS formation was assessed by measuring nitrotyrosine immunoreactivity. The immunoreactivity of inducible nitric oxide synthase (iNOS) in induced sputum and exhaled NO levels were also measured. Results: Treatment with steroids resulted in a significant reduction in both nitrotyrosine and iNOS immunoreactivity in sputum cells compared with pretreatment levels (both p<0.01). The reduction rates in both parameters were significantly related (p<0.05). The reduction in nitrotyrosine and iNOS immunoreactivity was correlated with the improvement in FEV1 (p<0.05) and airway responsiveness to histamine (p<0.01). None of the parameters was significantly changed by placebo administration. Conclusions: These results suggest that RNS may be involved in the reversible component of inflammation in COPD that is suppressed by steroids. Further studies using specific inhibitors for RNS are needed to clarify their effects on the long term progression of COPD.